Log In
Print
BCIQ
Print
Print this Print this
 

ATR-101

  Manage Alerts
Collapse Summary General Information
Company Atterocor Inc.
DescriptionSelective inhibitor of sterol O-acyltransferase 1 (SOAT1; ACAT1)
Molecular Target Sterol O-acyltransferase 1 (SOAT1) (ACAT1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAdenocarcinoma
Indication DetailsTreat adrenocortical carcinoma
Regulatory Designation

U.S. - Orphan Drug (Treat adrenocortical carcinoma);
EU - Orphan Drug (Treat adrenocortical carcinoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today